News of Note—Inovio and malaria vaccines

In this week's News of Note, an early-stage Lassa fever virus vaccine shows promise.

Here is some other vaccine news of note for this week.

> A Lassa fever virus vaccine developed by Inovio Pharmaceuticals and the U.S. Army provided 100% protection for non-human primates in a challenge study. Release

> Wellcome Trust Sanger Institute and its collaborators identified five targets that could be useful in developing malaria vaccines. Release